BIRC5 (Survivin) belongs to the inhibitor of apoptosis gene family. The BIRC5 protein inhibits caspases and consequently blocks apoptosis. Thus, BIRC5 contributes to the progression of cancer allowing for continued cell proliferation and survival. In this study, we identified eight sequence variants of BIRC5 through direct DNA sequencing. Among the eight single nucleotide polymorphisms (SNPs), six common variants with frequencies higher than 0.05 were selected for larger-scale genotyping (n=1,066). Results of the study did not show any association between the promoter region polymorphisms and the clearance of hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) occurrence. This is in line with a previous study in which polymorphisms in the promoter region does not influence the function of BIRC5. Initially, we were able to detect a signal with the ＋9194A＞G, which disappeared after multiple corrections but led to a change in amino acid. Similarly, we were also able to detect an association signal between two haplotypes (haplotype-2 and haplotype-5) on the onset age of HCC and/or HCC occurrence, but the signals also disappeared after multiple corrections. As a result, we concluded that there was no association between BIRC5 polymorphisms and the clearance HBV infection and/or HCC occurrence. However, our results might useful to future studies.
Introduction
Hepatitis B virus (HBV) infection, one of the most common virus infections among humans, is the major cause of acute and chronic liver diseases (Lin and Kao, 2008) . It affects approximately 350 million people every year, especially those in Asia, Africa, Southern Europe, and Latin America (Lok and McMahon, 2007) .
The clinical courses of HBV infection are diverse, ranging from spontaneous recovery after hepatitis to a chronic infection. The risk of developing liver cirrhosis (LC) or hepatocellular carcinoma (HCC) is higher for those who happen to be HBV chronic carriers as compared to the uninfected ones (Merican, Guan et al. 2000) . Several previous studies on HBV infection have reported that polymorphisms were associated with the risk of HCC and/or clearance of HBV (Kida et al., 2007; Kim et al., 2006; Park et al., 2006; Shin et al., 2003) .
BIRC5 (baculoviral inhibitor of apoptosis repeat-contaning 5), also known as survivin, is a protein encoded by the BIRC5 (Altieri 1994a; Altieri 1994b) . It belongs to the inhibitor of apoptosis (IAP) gene family. The BIRC5 protein functions to inhibit caspase activation, thus leading to a decrease in apoptosis or programmed cell death. This has been shown by increase in apoptosis and decrease in tumor growth by disruption of BIRC5 induction pathways. In addition, the BIRC5 protein is highly expressed in most tumor cells (Sah et al., 2006) . Because of this, BIRC5 is considered as one of the potent target for cancer therapy (Altieri, 2003) .
A previous study demonstrates that BIRC5 is associated with microtubules of the mitotic spindle at the start of mitosis through the disruption of microtubule formation after BIRC5 protein in cancer cells are knocked out. This appearance leads to polyploidy as well as massive apoptosis (Castedo et al., 2004) . Another study involves how the BIRC5 depleted cells exit mitosis without achieving proper chromosome alignment and then reforms single tetraploid nuclei. It suggests that BIRC5 protein is needed for sustaining mitotic arrest upon encounter with mitosis problems. The previous studies im- 
Sequence analysis of the human BIRC5
Using the ABI PRISM 3700 DNA analyzer (Applied Biosystems, Foster City, CA), we sequenced exons, introns, and the promoter region (∼1.5) to discover variants from 24 unrelated individual's DNA samples. Primer sets for the amplification and sequencing analysis of BIRC5 were designed based on GenBank sequences. Sequence analysis was carried out using SeqMan Ⓡ software.
Genotyping with fluorescence polarization detection
Amplifying primers and probes were designed for TaqMan Ⓡ (An et al., 2002) which was used for genotyping of the six polymorphic sites. Primer Express (Applied Biosystems) was used to design both the PCR primers and the MGB TaqMan probes. One allelic probe was labeled with FAM dye and the other with fluorescent VIC dye. Typically, PCR was run in the TaqMan Universal Master mix without UNG (Applied Biosystems) at primer concentration of 900 nM and TaqMan MGB-probe con- 
Statistics
We examined Lewontin's D' (|D'|) and LD coefficient r 2 between all pairs of biallelic loci (Hedrick, 1987) . Haplotypes of each individual were determined using the algorithm developed by Stephens et al. (Stephens et al., 2001 ), which (PHASE) uses a Bayesian approach incorporating priori expectations of haplotypic structure from population genetic and coalescent theory. Genetic effects of inferred haplotypes were analyzed in the same way as SNPs. Logistic regression models were used for calculating odds ratios (95% confidential interval) and corresponding P-values controlling for age (continuous value) and sex (male=0, female=1) as covariates. In our analysis on HCC occurrence, LC (LC=1, no LC=0) and HBeAg (negative=0, blank=1, positive=2) were also used as covariates. Statistical powers were also calculated using PGA matlab application (Menashe, Rosenberg et al. 2008) . PGA is designed to calculate statistical power and other values of case-control genetic association studies. In this study, a co-dominant (1df) model, relative risk 1.3, disease prevalence value 7.1% (Lee, Kim 
Results
We identified eight genetic variants in BIRC5 using di- Table 2 ). The logistic analysis for clearance of HBV infection, HCC occurrence, and onset age of HCC occurrence, as well as the p-values of each polymorphisms, haplotypes, and statistical powers are displayed in Table 3 . In the case of SNPs, among the eight variants detected by direct sequencing, six were selected for the association analysis of the clearance of HBV infection and HCC occurrence. Two SNPs (−241C＞T and ＋9625G＞A)
were excluded from the analysis due to low frequencies, 0.021 and 0.022 respectively. Among the six polymorphisms, −644T＞C in the promoter region showed an association signal with HCC occurrence (p=0.04) and onset age of HCC (p=0.05) before correction was conducted, whereas the other SNPs in the promoter regions showed no association signals in all the analysis. An association with the clearance of HBV infection before correction was also detected in ＋9194A＞G (p=0.04), which led to a change in amino acid lysine to glutamate.
Another association analysis was conducted for haplotypes. Five haplotypes with frequencies greater than 5% were selected for analysis. The selected haplotypes were able to explain more than 96% of the distribution (Fig 1B) . Linkage disequilibrium coefficients (|D'|) between all SNP pairs were also shown (Fig. 1C) . Among the haplotypes that we selected for analysis, haplotype-5 [T-T-G-A-T-C] showed an association with the clearance of HBV infection (p=0.01) and haplotype-2 [T-T-G-G-T-T] showed an association in onset age of HCC analysis (p=0.03) before correction Table 3 .
Discussion
BIRC5 serves as a major factor in cancer development by contributing to the resistance of cancer cells to apoptosis (Hedrick, 1987) . BIRC5 has been known to be involved in cell-cycle progression by bypassing cell-cycle checkpoints leading to continued proliferation (Ambrosini et al., 1998) . This can be explained by the fact that tumor cells can divide without breaking and eventually survive. In addition, a previous study has reported that the expression level of BIRC5 in hepatocellular carcinoma cells is higher than in other cancer-causing cells (Montorsi et al., 2007) . With the role played by BIRC5 in cancer development, we hypothesized that BIRC5 polymorphisms were associated with the clearance of HBV infection and/or HCC occurrence.
Previous studies have reported three polymorphisms (−644T＞C, −625G＞C, −31C＞G) involved in the study of lung cancer in a Korean population (n=582) (Jang et al., 2008) and seven polymorphisms (−267G＞ Logistic regression models were used for calculating odds ratios (95% confidential interval) and corresponding P-values for each SNP site and haplotype controlling age and sex as covariates using SAS. Age (continuous value) and sex (male=0, female=1) were adjusted by including logistic analysis as covariables. All patients included in this study were HBsAg-positive (chronic hepatitis). Cox models were used for calculating onset age of HCC and P-values for SNPs and haplotypes, controlling age, sex, adjusted age (age＜40, adjage=0; 40＜=age＜60, adjage=1; age＞60, adjage=2), LC (LC=0, no LC=1), and HBeAg (negative=0, positive=1) by SAS. All patients also included in this Table were HBsAg-positive (chronic HBV).
*To achieve the optimal correction for multiple testing of single nucleotide polymorphisms (SNPs) in linkage disequilibrium (LD) with each other, the effective number of independent marker loci (4.58) in BIRC5 was calculated using the software SNPSpD (http://genepi.qimr.edu.au/general/daleN/SNPSpD/) on the basis of spectral decomposition (SpD) of matrices of pair-wise LD between the SNPs. Statistical power of single associations was calculated with alpha error level of 5%, disease prevalence of 7.1%, given minor allele frequencies and sample sizes, and assuming a relative risk of 1.3, using PGA (Power for Genetic Association Analyses) software (http://dceg.cancer.gov/bb/tools/pga).
Bold values indicate the case of p＜0.05
A, −241C＞T, −235G＞A, −198, −191, −141 and −31C＞G) studied for breast carcinoma in a French population (n=191) (Boidot et al., 2008) . Among the promoter region polymorphisms that were studied in both Korean and French populations, −31C＞G has been considered to play an important role in cancer development by affecting the expression level of mRNA of BIRC5 (Yang et al., 2009) . Furthermore, two studies concerning cancer in Taiwan and China populations also examined the −31C＞G polymorphism Yang et al., 2009) . In contrast, one study reported that the polymorphisms in the promoter region, including −31C＜G does not have any influence on the BIRC5 activity (Boidot et al., 2008 (Marusawa et al., 2003) . Moreover, in another SNP study, Jang et al. reported that ＋9194A＞G might be related with cancer (Jang et al., 2008) . According to the study if alteration of amino acid by ＋9194A＞G in exon4 affects protein formation, then it will also affect the interaction of HBXIP and BIRC5. In this study, ＋9194A＞G initially showed an association signal with clearance of HBV infection. Although the signal disappeared after multiple testing corrections, it might provide valuable meaning to studies on the function of BIRC5. In summary, we have identified eight polymorphisms in the human BIRC5 gene that were used to locate six common polymorphic sites selected for large-scale genotyping. After conducting a test on the functions of the promoter region polymorphisms, statistical analysis displayed no association among polymorphisms in the promoter region with the clearance of HBV infection and/or HCC occurrence. In addition, ＋9194A＞G initially showed an association signal with the clearance of HBV infection and led to transformation of amino acid.
We also found that haplotype-2 and haplotype-5 initially showed association signals with HBV infection and the onset age of HCC analysis, respectively. However, all association signals disappeared after multiple testing corrections, which led us to conclude that there was no association between BIRC5 polymorphisms and the clearance of HBV infection and/or HCC occurrence. Although our p-values did not undergo multiple testing corrections, results from this study might be useful for future researches which should include additional investigation on the function and/or expression of the polymorphisms of BIRC5. 
